ASTRAZENECA PLC
Price data unavailable
Track AZN in your trading journalAbout ASTRAZENECA PLC
ASTRAZENECA PLC (AZN) is a publicly traded US company. A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Investors tracking AZN can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.
Fundamentals
| Revenue (TTM) | — |
| Net Income (TTM) | — |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | — |
| Debt-to-Equity | — |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·May 20
ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight
- GlobeNewswire Inc.·May 18
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- GlobeNewswire Inc.·May 18
Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight
Want real-time analysis on AZN?
Track it free in your trading journal. Log trades, tag setups, and review your edge.